stem cells

FDA has a date for stem cells hearing

The Food and Drug Administration has rescheduled a critical public hearing on potential regulations for the burgeoning stem cell industry. “Request for Comments – Draft Guidances Relating to the Regulation of Human Cells, Tissues or Cellular or Tissue-Based Products” will now be held Sept.12 and 13 inside the Masur Auditorium on the National Institutes of Health’s Bethesda, Md. campus. Originally scheduled for April 13, the hearing was postponed due to what the FDA called “considerable…


FDA pushes off stem cell hearing

The Food and Drug Administration has indefinitely postponed a public hearing on stem cell regulation due to what it called “considerable interest.” “Due to this interest, and to give stakeholders additional time to provide comments to the agency, FDA intends to extend the comment period for the draft guidance documents,” the administration said on its website. The April 13 hearing was shaping up as a public showdown between opponents and supporters of stem cell-based research…


The FDA seeks a cure for stem cell quackery

By GREGORY ZELLER // With federal regulators looming and a charged FDA hearing set for later this year, the nation’s stem cell community is tense, particularly clinicians incorporating stem cell therapies in private practice. Scientifically, stem cells are on the rise. Therapies cultivating stem cells from a patient’s own body are increasingly common treatments for autism, various cancers, joint injuries and a host of other ailments; nutritionists push supplements infused with stem cells, goji berry and…